Schedule 13G ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Security class unavailable · CUSIP: 09058V103
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,150,211
- Percent of class
- 7.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000834237-20-004615
- Form type
- SC 13G
- Filer
- BIOCRYST PHARMACEUTICALS INC
- CIK
- CIK 882796
- Filed
- Feb 05, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership